Literature DB >> 30710058

ADP-ribosylation and intracellular traffic: an emerging role for PARP enzymes.

Giovanna Grimaldi1, Daniela Corda1.   

Abstract

ADP-ribosylation is an ancient and reversible post-translational modification (PTM) of proteins, in which the ADP-ribose moiety is transferred from NAD+ to target proteins by members of poly-ADP-ribosyl polymerase (PARP) family. The 17 members of this family have been involved in a variety of cellular functions, where their regulatory roles are exerted through the modification of specific substrates, whose identification is crucial to fully define the contribution of this PTM. Evidence of the role of the PARPs is now available both in the context of physiological processes and of cell responses to stress or starvation. An emerging role of the PARPs is their control of intracellular transport, as it is the case for tankyrases/PARP5 and PARP12. Here, we discuss the evidence pointing at this novel aspect of PARPs-dependent cell regulation.
© 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  ADP-ribosylation; Golgi apparatus; PARP enzymes; intracellular transport; poly-ADP-ribose; stress response

Mesh:

Substances:

Year:  2019        PMID: 30710058     DOI: 10.1042/BST20180416

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  10 in total

Review 1.  Poly(ADP-Ribosylation) in Age-Related Neurological Disease.

Authors:  Leeanne McGurk; Olivia M Rifai; Nancy M Bonini
Journal:  Trends Genet       Date:  2019-06-07       Impact factor: 11.639

Review 2.  Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules.

Authors:  Maria Giulia Nizi; Mirko M Maksimainen; Lari Lehtiö; Oriana Tabarrini
Journal:  J Med Chem       Date:  2022-05-24       Impact factor: 8.039

Review 3.  Systems approach to rational combination therapy: PARP inhibitors.

Authors:  Chaoyang Sun; Yong Fang; Marilyne Labrie; Xi Li; Gordon B Mills
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

Review 4.  Translating around the clock: Multi-level regulation of post-transcriptional processes by the circadian clock.

Authors:  Amber A Parnell; Aliza K De Nobrega; Lisa C Lyons
Journal:  Cell Signal       Date:  2020-12-25       Impact factor: 4.315

5.  ADP-ribosyltransferases, an update on function and nomenclature.

Authors:  Bernhard Lüscher; Ivan Ahel; Matthias Altmeyer; Alan Ashworth; Peter Bai; Paul Chang; Michael Cohen; Daniela Corda; Françoise Dantzer; Matthew D Daugherty; Ted M Dawson; Valina L Dawson; Sebastian Deindl; Anthony R Fehr; Karla L H Feijs; Dmitri V Filippov; Jean-Philippe Gagné; Giovanna Grimaldi; Sebastian Guettler; Nicolas C Hoch; Michael O Hottiger; Patricia Korn; W Lee Kraus; Andreas Ladurner; Lari Lehtiö; Anthony K L Leung; Christopher J Lord; Aswin Mangerich; Ivan Matic; Jason Matthews; George-Lucian Moldovan; Joel Moss; Gioacchino Natoli; Michael L Nielsen; Mario Niepel; Friedrich Nolte; John Pascal; Bryce M Paschal; Krzysztof Pawłowski; Guy G Poirier; Susan Smith; Gyula Timinszky; Zhao-Qi Wang; José Yélamos; Xiaochun Yu; Roko Zaja; Mathias Ziegler
Journal:  FEBS J       Date:  2021-07-29       Impact factor: 5.622

Review 6.  Regulation of Glucose Metabolism by NAD+ and ADP-Ribosylation.

Authors:  Ann-Katrin Hopp; Patrick Grüter; Michael O Hottiger
Journal:  Cells       Date:  2019-08-13       Impact factor: 6.600

Review 7.  Targeting ADP-ribosylation as an antimicrobial strategy.

Authors:  Giuliana Catara; Annunziata Corteggio; Carmen Valente; Giovanna Grimaldi; Luca Palazzo
Journal:  Biochem Pharmacol       Date:  2019-06-06       Impact factor: 5.858

Review 8.  Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy.

Authors:  Ubaldina Galli; Giorgia Colombo; Cristina Travelli; Gian Cesare Tron; Armando A Genazzani; Ambra A Grolla
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

9.  PKD-dependent PARP12-catalyzed mono-ADP-ribosylation of Golgin-97 is required for E-cadherin transport from Golgi to plasma membrane.

Authors:  Giovanna Grimaldi; Angela Filograna; Laura Schembri; Matteo Lo Monte; Rosaria Di Martino; Marinella Pirozzi; Daniela Spano; Andrea R Beccari; Seetharaman Parashuraman; Alberto Luini; Carmen Valente; Daniela Corda
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-04       Impact factor: 12.779

Review 10.  PARP-1 Is a Potential Marker of Retinal Photooxidation and a Key Signal Regulator in Retinal Light Injury.

Authors:  Xun Li; ZiYuan Zhang; Bin Fan; YuLin Li; DeJuan Song; Guang-Yu Li
Journal:  Oxid Med Cell Longev       Date:  2022-09-10       Impact factor: 7.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.